Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: Influence of reduction in intravenous dosage
Authors:
- Andrew W. GoddardAGAndrew W. Goddard
- Diane E. SholomskasDSDiane E. Sholomskas
- Scott W. WoodsSWScott W. Woods
- Dennis S. CharneyDCDennis S. Charney
- George R. HeningerGHGeorge R. Heninger
- 30 November 1994
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 54 (2) , 115-133
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Neuroendocrine Responses to m-Chlorophenylpiperazine and i-Tryptophan in BulimiaArchives of General Psychiatry, 1992
- Does metergoline selectively attenuate 5-HT mediated prolactin release?Psychopharmacology, 1991
- m-CPP: a tool for studying behavioural responses associated with 5-HT1c receptorsTrends in Pharmacological Sciences, 1990
- Serotonergic Studies in Patients With Affective and Personality DisordersArchives of General Psychiatry, 1989
- Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacksAmerican Journal of Psychiatry, 1987
- Serotonin function in anxietyPsychopharmacology, 1987
- Abnormal Regulation of Noradrenergic Function in Panic DisordersArchives of General Psychiatry, 1986
- α2Adrenergic and Opiate Receptor BlockadeArchives of General Psychiatry, 1986
- A cognitive approach to panicBehaviour Research and Therapy, 1986
- (—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodoneJournal of Pharmacy and Pharmacology, 1981